NEW YORK (GenomeWeb) – Pacific Biosciences on Thursday filed a shelf registration to offer up to $150 million of its securities.

According to a document filed with the US Securities and Exchange Commission, the company may offer and sell from time to time shares of its common stock, preferred stock, depositary shares, warrants, debt securities, or units comprising its securities.

PacBio previously filed a $150 million shelf registration in April 2012.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.